SCHEMBL7417255

SCHEMBL7417255

COC(=O)Cc1ccc(OS(=O)(=O)C(F)(F)F)c(NC(C)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PDK2 Q15119 1/20 0.42
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 4/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
GAA P10253 2/20 0.39
GFER P55789 1/20 0.39
CA5A P35218 1/20 0.39
MEN1 O00255 3/20 0.38
SLC7A5 Q01650 1/20 0.38
RECQL P46063 1/20 0.38
PPARA Q07869 1/20 0.38
MGAT2 Q10469 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8553661 0.86 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19PDK2ALDH1A1
SCHEMBL4842048 0.83 CA5A (0.58) CYP1A2CYP2C19PDK2ALDH1A1KMT2A
SCHEMBL30154424 0.83 CYP4F2 (0.43) PDK2ALDH1A1CYP4F2CYP4A11GAA
SCHEMBL5738807 0.83 CA5A (0.51) CYP1A2CYP2C19PDK2ALDH1A1KMT2A
SCHEMBL2126108 0.83 CYP4F2 (0.43) PDK2ALDH1A1CYP4F2CYP4A11GAA
SCHEMBL2127345 0.83 CYP4F2 (0.43) PDK2ALDH1A1CYP4F2CYP4A11GAA
SCHEMBL2124578 0.81 RXRA (0.43) PDK2ALDH1A1KMT2ACYP4F2CYP4A11
SCHEMBL2125942 0.81 LMNA (0.43) PDK2ALDH1A1CYP4F2CYP4A11GAA
SCHEMBL7420742 0.81 GAA (0.55) CYP1A2CYP2C19PDK2ALDH1A1KMT2A
SCHEMBL8237704 0.81 SMN1; SMN2 (0.48) ALDH1A1KMT2ACYP4F2CYP4A11GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed